Long-term evaluation and physical and mental effects of residual tinnitus following treatment of sudden hearing loss / 中华耳鼻咽喉头颈外科杂志

Objective: To clarify the long-term characteristics of tinnitus following treatment of sudden deafness and its long-term physical and mental effects on patients. Methods: A retrospective analysis was performed on 88 patients (46 males and 42 females; Age from 11 to 89 years) with sudden deafness treated in Department of Otoscope Surgery of Peoples's Libration Army General Hospital in Beijing from April 2020 to January 2021, and the occurrence of tinnitus and treatment effect of all patients were analyzed. Follow-up was conducted for patients with residual tinnitus after treatment for more than 1 year by the investigation and filling in the survey information collection form, Tinnitus Evaluation Questionnaire (TEQ) and Tinnitus Handicap Inventory (THI). Descriptive statistics and SPSS 22.0 software were used for statistical data analysis. Results: In this study, 93.2% (82/88) of patients with sudden deafness were accompanied by tinnitus at the onset, and the proportion of long-term tinnitus after treatment was 90.2% (74/82). After 1 year of treatment for sudden deafness, the improvement of tinnitus was significant in low-frequency sudden deafness compared with those of high-frequency, flat and total deafness sudden deafness (χ2 value was 6.801, 4.568 and 4.038, all P<0.05). In patients with residual tinnitus, 9 (12.2%) patients felt minimal loudness or even no loudness, 34 (46.0%) patients felt slight loudness, 28 (37.8%) patients felt tinnitus was relatively loud, and 3 (4.1%) patients felt tinnitus was loud or noisy. Nine (12.2%) patients's sleep was often affected, 41 (55.4%) patients's sleep was sometimes affected, 9 (12.2%) patients's sleep was rarely affected, 15 (20.3%) patients's sleep was almost not affected. Twenty-eight (37.8%) patients basically completely adapted to tinnitus and 46 (62.2%) patients did not completely adapted to residual tinnitus. Eight (10.8%) patients had no impact on life, 39 (52.7%) patients had slight impact, 22 (29.7%) patients had moderate impact, and the other 5 (6.8%) patients had greater impact. According to tinnitus evaluation questionnaire(TEQ), there were 12 cases (16.2%) of grade Ⅰ, 26 cases (35.1%) of grade Ⅱ, 28 cases (37.8%) of grade Ⅲ, 7 cases (9.5%) of grade Ⅳ and 1 case (1.4%) of grade Ⅴ. According to tinnitus handicap inventory(THI), tinnitus disability was classified into grade Ⅰ, 22 cases (29.7%), grade Ⅱ, 14 cases (18.9%), Grade Ⅲ, 27 cases (36.5%) and grade Ⅳ, 11 cases (14.9%). Conclusion: The rate of residual tinnitus following treatment of sudden deafness is high. Some of the patients can completely adapt residual tinnitus after one year, but some of them will be affected when sleep, work and study. Residual tinnitus can lead to tinnitus disability in different degrees.

Effect of different electroacupuncture stimulation parameters on sudden hearing loss / 中国针灸

OBJECTIVE@#To compare the efficacy of different electroacupuncture (EA) frequencies and wave patterns combined with medication and medication alone for sudden hearing loss (SHL), and to explore better electroacupuncture stimulation parameters.@*METHODS@#All of 118 patients with SHL were randomly divided into an acupuncture and medication group 1 (group 1, 30 cases, 1 case dropped off), an acupuncture and medication group 2 (group 2, 30 cases), an acupuncture and medication group 3 (group 3, 31 cases) and a medication group (27 cases, 1 case dropped off ). The patients in the medication group were treated with conventional medication. On the base of the medication group, the patients in the group 1, 2, and 3 were treated with acupuncture at Ermen (TE 21), Tinggong (SI 19), Tinghui (GB 2), Fengchi (GB 20), etc. on the affected side, and EA at Ermen (TE 21)-Yifeng (TE 17), Tinghui (GB 2)-Yifeng (TE 17) alternately. The 3 groups were given continuous wave with frequency of 2 Hz, continuous wave with frequency of 50 Hz, and disperse-dense wave with frequency of 2 Hz/50 Hz respectively. The treatment was given once a day, 10 days were as one course, with 2 courses in total. Before and after treatment, the pure tone hearing threshold test was performed, and the curative effect of pure tone hearing threshold test and the curative effect of tinnitus, ear fullness and dizziness were compared in the 3 groups.@*RESULTS@#After treatment, the pure tone hearing threshold test values of each group were lower than those before treatment (@*CONCLUSION@#On the basis of conventional medication treatment, the addition of electroacupuncture can effectively improve the hearing and ear stuffiness symptoms of patients with SHL, and the disperse-dense wave with frequency of 2 Hz/50 Hz is more effective.

Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities

Abstract Introduction Idiopathic sudden sensorineural hearing loss (ISSNHL) is hearing loss of at least 30 dB in at least 3 contiguous frequencies within at least 72 hours. There are many different theories to explain it, and many differentmodalities are used for its management, such as: systemic steroids (SSs), intratympanic steroid injection (ITSI), hyperbaric oxygen therapy (HOT), antiviral drugs, and vasodilators or vasoactive substances. Objectives This study aims to evaluate the efficacy of the combination of the most common treatmentmodalities of ISSNHL and to compare the results if HOTwas not one of the treatment modalities administered. Methods The study was conducted with 22 ISSNHL patients with ages ranging from 34 to 58 years. The patients were divided into 2 groups; group A included 11 patients managed by SSs, ITSI, antiviral therapy, and HOT simultaneously, and group B included 11 patients exposed to the aforementioned modalities, with the exception of HOT. Results After one month, all of the patients in group A showed total improvement in hearing in all frequencies, with pure tone average (PTA) of 18.1 ± 2.2, while in group B, 5/11 (45.5%) patients showed total improvement, and 6 /11 (54.5%) patients showed partial improvement, with a total mean PTA of 28.1 ± 8.7. Conclusion The early administration of HOT in combination with other clinically approved modalities (SSs, ITSI, antiviral therapy) provides better results than the administration of the same modalities, with the exception of HOT, in the treatment of ISSNHL.

The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss / O papel da oxigenoterapia hiperbárica e da ozonioterapia na surdez súbita

Abstract Introduction: It is difficult to evaluate the effect of drugs clinically used for idiopathic sudden sensorineural hearing loss, mainly because its underlying mechanism remains unknown. Objective: This study assessed the efficacy of hyperbaric oxygen therapy or ozone therapy in the treatment of idiopathic sudden sensorineural hearing loss, when either therapy was included with steroid treatment. Methods: A retrospective analysis examined 106 patients with idiopathic sudden sensorineural hearing loss seen between January 2010 and June 2012. Those with an identified etiology were excluded. The patients were divided into three treatment groups: oral steroid only (n = 65), oral steroid + hyperbaric oxygen (n = 26), and oral steroid + ozone (n = 17). Treatment success was assessed using Siegel criteria and mean gains using pre- and post-treatment audiograms. Results: The highest response rate to treatment was observed in the oral steroid + ozone therapy group (82.4%), followed by the oral steroid + hyperbaric oxygen (61.5%), and oral steroid groups (50.8%). There were no significant differences in the response to treatment between the oral steroid and oral steroid + hyperbaric oxygen groups (p < 0.355). The oral steroid + ozone group showed a significantly higher response rate to treatment than the oral steroid group (p = 0.019). There were no significant differences between the oral steroid + hyperbaric oxygen and oral steroid + ozone groups (p = 0.146). Conclusion: The efficiency of steroid treatment in patients with severe hearing loss was low. It was statistically ascertained that adding hyperbaric oxygen or ozone therapy to the treatment contributed significantly to treatment success.

Resumo Introdução: É difícil avaliar o efeito dos fármacos clinicamente usados na surdez súbita idiopática, principalmente porque o seu mecanismo subjacente se mantém desconhecido. Objetivo: Avaliar a eficácia da oxigenoterapia hiperbárica ou ozonioterapia no tratamento de surdez súbita, quando uma ou outra terapia é incluída no tratamento com esteroides. Método: Uma análise retrospectiva examinou 106 pacientes com surdez súbita atendidos entre janeiro de 2010 e junho de 2012. Aqueles com uma etiologia identificada foram excluídos. Os pacientes foram divididos em três grupos de tratamento: apenas esteroide oral (n = 65), esteroide por via oral + oxigenoterapia hiperbárica (n = 26) e esteroides por via oral + ozônio (n = 17). O sucesso do tratamento foi avaliado com critérios de Siegel e os ganhos médios com audiogramas pré e pós-tratamento. Resultados: A taxa de resposta mais elevada para o tratamento foi observada no grupo de esteroide + ozonioterapia (82,4%), seguida por grupos de esteroide oral + oxigenoterapia hiperbárica (61,5%) e esteroide oral (50,8%). Não houve diferenças significantes na resposta ao tratamento entre os grupos de esteroide oral e esteroides + oxigenoterapia hiperbárica (p < 0,355). O grupo de esteroide oral + ozônio apresentou uma taxa de resposta significantemente mais elevada ao tratamento do que o grupo de esteroide oral (p = 0,019). Não houve diferenças significantes entre os grupos de esteroide oral + oxigenoterapia hiperbárica e esteroide oral + ozônio (p = 0,146). Conclusão: A eficiência do tratamento com esteroides em pacientes com perda auditiva grave foi baixa. Verificou-se estatisticamente que a adição de oxigenoterapia hiperbárica ou ozonioterapia ao tratamento contribuiu significantemente para o sucesso do tratamento.

Sordera súbita: a la luz de la evidencia / Sudden deafness: in light of the evidence

La sordera súbita es una condición de hipoacusia neurosensorial aguda usualmente unilateral, de instalación en un período menor o igual a 72 horas, que en la mayoría de los casos es idiopática; sin embargo, causas infecciosas, autoinmunes y vasculares, se han propuesto como los principales mecanismos involucrados. La sordera súbita es considerada una urgencia otorrinolaringológica, sin embargo el tratamiento de ésta continúa siendo un tema controvertido.

Sudden deafness is usually a condition of acute unilateral sensorineural hearing loss, installation less than or equal to 72 hours period, which in most cases are idiopathic; however, infectious, autoimmune and vascular causes, have been proposed as key mechanisms involved. Sudden deafness is considered an ENT urgency, however this treatment remains controversial.

Sordera súbita: estudio retrospectivo sobre 40 casos ingresados en nuestro hospital / Sudden deafness: a retrospective study of 40 cases admitted to our hospital

Introducción: La sordera brusca es una pérdida súbita de audición a nivel neuro-sensorial, por causas desconocidas, y con mal pronóstico funcional. Las causas son desconocidas, lo que genera múltiples hipótesis y discusiones sobre esta patología. Objetivo: Evaluar los factores asociados al pronóstico y determinar los aspectos terapéuticos que influyen en el pronóstico de estos pacientes. Material y método: Revisamos las historias clínicas de los pacientes diagnosticados de sordera brusca durante un período de estudio de 4 años, y calculamos las frecuencias de las diferentes variables consideradas como relevantes; realizamos análisis bivariante y una comparación de las distribuciones mediante test de ANOVA y un análisis multivariante con regresión logística y lineal múltiple. Resultados: Analizamos 40 casos. Consideramos factores como el oído afectado, antecedentes cardiovasculares, HTA, diabetes, dislipemia, tabaco, hemoglobina, hematocrito, las circunstancias temporales y geográficas, de las que ninguna de ellas resultaron significativas para la recuperación. Tras el análisis de otros factores, encontramos un predominio de casos en verano y otoño (90 por ciento) frente a invierno y primavera (10 por ciento). El uso del famciclovir estuvo asociado a mayor probabilidad de recuperación completa OR 21,164 [1,265-374,47]. Por el contrario, estuvieron ligados a una menor probabilidad de recuperación completa: el tratamiento con medicina hiperbárica OR 0,013 [0,001-0,433], la curva audiométrica descendente OR 0,164 [0,032-0,533], y la presencia de vértigo asociada a acúfenos OR 0,158 [0,08-1,015]. La aspirina mejoró la recuperación de decibelios media 24,3 db IC 95 por ciento [1,00-47,61]. Conclusiones: El estudio es una serie retrospectiva cuyo análisis multivariante muestra que el famciclovir y el AAS tienen un efecto estadísticamente beneficioso en el tratamiento de la sordera súbita...

Introduction: The sudden deafness is a sudden loss of hearing at the neuro-senso-rial, for unknown reasons, and bad functional prognosis. The cause is unknown, generating multiple hypotheses and discussions on this topic. Aim: To evaluate the factors associated with prognosis and determine therapeutic aspects that influence the prognosis of these patients. Matherial and method: We reviewed the medical records ofpatients diagnosed with sudden hearing loss during a study period of 4 years, and calculate the frequencies of the different variables considered relevant; performed bivariate analysis and a comparison of the distributions byANOVA and a multivariate analysis with logistic regression and multiple lineal. Results: We analyzed 40 cases. We consider factors like the affected ear, cardiovascular history, hypertension, diabetes, dyslipidemia, snuff, hemoglobin, hematocrit, temporal and geographical, of which none were significant for recovery. After analysis of other factors, we found a predominance of cases in summer and autumn (90 percent) compared to winter and spring (10 percent). Use of famciclovir was associated with greater likelihood of complete recovery OR 21.164 [1.265 to 374.47]. On the contrary, were linked to a lower linked to a lower likelihood of full recovery: treatment with hyperbaric OR 0.013 [0.0010.0433] OR descending audiometric curve [0.164 0.032 to 0.533] and the presence of vertigo associated with tinnitus OR o.158 [0.08 to 1.015]. Aspirin improved recovery of 24.3 db decibel half 95 percent CI [1.00 to 47.61]. Conclusions: The study is a retrospective multivariate analysis which shows that famciclovir and aspirin have a statisfically beneficial in the treatment of sudden deafness, which in our sample is more frequent in summer and autumn. Biased studies are needed on these results may provide new hypotheses for treatment.

Informe de evaluación rápida de tecnología sobre seguridad y efectividad de la oxigenoterapia hiperbárica / Rapid evaluation report of technology on safety and effectiveness of hyperbaric oxygen therapy

La oxigenación hiperbárica es una modalidad terapéutica no invasiva en la cual el pacientes respira oxígeno puro en el interior de una cámara de acero herméticamente cerrada, a presión atmosférica mayor a la ambiental (cámara hiperbárica). Existen solo dos efectos básicos que describen el mecanismo de acción de la OHB en el cuerpo humano, los cuales son: a. El efecto volumétrico, producido por la presión aumentada a la cual se somete el organismo. Dicho efecto es de fundamental importancia en la reducción del tamaño de las burbujas de gas que pueden contener los tejidos corporales como consecuencia de un accidente de buceo o iatrogenia médica (embolismo gaseoso en las intervenciones quirúrgicas u otros procedimientos terapéuticos invasivos), o el producido por bacterias anaerobias. b. El segundo efecto es solumétrico, debido al incremento de la presión parcial de oxígeno en los tejidos, siendo este multifacético, ya que a las presiones atmosféricas manejadas en este tratamiento el oxígeno se comporta como un fármaco con indicaciones específicas y posibles efectos adversos. Se recomienda cubrir en las siguientes condiciones: enfermedad por descompresión, embolia gaseosa, gangrena gaseosa, intoxicación por monóxido de carbono, fasceitis necrotizante, gangrena de Fournier, lesiones de pie diabético grado IV de Wagner, lesiones de bóveda craneal, parrilla costal, esternón, mandíbula, proctitis y enteritis.(AU)

[Hyperbaric oxygen [HBO] on sudden hearing loss about 69 cases]

Sudden hearing loss is a typical otologic urgency. The pathophysiological mechanisms and the definition of sudden deafness are controversed. Several therapeutic diagrams were proposed for the management of this sensorineural urgency. But therapeutic results were not estimated to be efficient with conventional medical treatments. The purpose of the study: The authors report this study to evaluate the efficiency of hyperbaric oxygen [HBO] on sudden hearing loss, to revise factor prognosis and finally to seek for clinical forms of sudden deafness in which HBO must be primary indicated. A retrospective study was performed on 69 patients with sudden deafness, treated by HBO after unfavourable evolution under conventional treatments: In spite of the late time [20 days], fifty six percent of the patients had a satisfactory recovery. Efficiency of HBO was improved when it is practiced before the tenth day of the affection [92%]. Finally, this study shows an excellent systemic tolerance of HBO; since no severe incidents were recorded

Hipoacusia súbita: experiencia clínica con 54 pacientes / Sudeafness: experience in 54 patients

La hipoacusía súbita es una emergencia otorrinolaringológica, en la cual existe una pérdida auditiva mayor de 30 decibeles, que se desarrolla en menos de 3 días, en tres frecuencias contíguas. Se han desarrollado en el transcurso de los años una serie de propuestas terapeúticas para el manejo pronto y adecuado de esta patología, de origen multifactorial y con una gran gama de manifestaciones clínicas acompañantes. El objetivo de nuestro estudio fue determinar el grado de recuperación auditiva en una muestra de 54 pacientes con hipoacusía súbita, utilizando un esquema de tratamiento consistente en la asociación de agentes hemorreológicos y esteroides, con variables determinadas en base a grupos de edad, sexo, enfermedad uni o bilateral, etiología probable y grado de la hipoacusía. En base al analisis de los resultados, observamos que el 95 por ciento de los pacientes tratados mostraron diversos grados de recuperación de la agudeza auditiva al término del estudio

Surdez súbita / Suden sensorial hearing loss

Os autores fazem uma revisäo e descrevem o caso de um paciente com surdez súbita em que foi realizada a hemodiluiçäo normovolêmica como único tratamento para a patologia, ressaltando as vantagens desta técnica

Síndrome de sordera por inhibición retrococlear eferente / Deafness syndrome caused by efferent retrococlear inhibition

Presento bajo este nombre de RIED syndrome, al cuadro clínico caracterizado por sordera sensorioneural súbita o rápidamente progresiva, acompañado de acúfenos y ocasionalmente de mareos, y todo esto relacionado con una situación estresante, que se produce en personas con personalidad tensa, perfeccionista e incapaces de relajarse. Se describe el posible mecanismo de esta inhibición activa eferente sobre uno o ambos oídos, desde la corteza, víageniculado medial al colículo inferior y desde éste al ramo olivo cóclear, cuyas neuronas eferentes terminan en las células ciliadas externas. El posible modo de actuar de esta inhibición retrococlear eferente, sería a través de alterar el funcionamiento normal de las células ciliadas externas, las que cesarían en función amplificadora y moduladora, causando sordera y acúfenos posiblemente por alteración inmediata de la señal que se origina en las células ciliadas y que va hasta la corteza por la vía aferente. Por el tipo de personalidad de los enfermos en que se manifiesta este síndrome de sordera por inhibición retrococlear eferente, se postura que podría haber un trastorno en los neurotransmisores; similar al que se ve en la depresión endógena, y esta falla actuaría en los núcleos geniculado medial y colículo inferior, haciendo fallar el control eferente que éste ejerce sobre la cóclea

Hemodiluiçäo normovolêmica no tratamento da surdez súbita: resultados iniciais / Normovolemic hemodilution in sudden deafness treatment: first results

A hemodiluiçäo normovolêmica é apresentada como uma forma de tratamento da surdez súbita. A técnica consiste na retirada de determinado volume sanguíneo do paciente e, a sua reposiçäo simultânea, com soluçäo de Dextran. Com este método promove-se uma queda no hematócrito com a consequente diminuiçäo da viscosidade sanguínea e aumento do fluxo capilar. Obtém-se, desta forma, um maior aporte de oxigênio a nível da circulaçäo coclear. Nos 10 primeiros pacientes submetidos a esta terapêutica, os autores comentam a simplicidade e segurança do método, assim como, a aparente eficácia pelos resultados inicialmente obtidos